JENKINTOWN, Pa., March 7, 2025 /PRNewswire/ -- SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small-molecule biosynthetic compounds for the treatment of ...
JENKINTOWN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) -- SFA Therapeutics, a clinical-stage biotech using a first-in-class immuno-modulation technology platform, announced positive results from their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results